COMPARISON OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) ON DISEASE REMISSION IN THE EUROPEAN UNION (EU) AND UNITED STATES (US)

被引:0
|
作者
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Baskett, A. [2 ]
机构
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS82
引用
收藏
页码:A167 / A167
页数:1
相关论文
共 50 条
  • [21] Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
    Bergman, Martin
    Zhou, Lili
    Patel, Pankaj
    Sawant, Ruta
    Clewell, Jerry
    Tundia, Namita
    [J]. ADVANCES IN THERAPY, 2021, 38 (05) : 2558 - 2570
  • [22] Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
    Martin Bergman
    Lili Zhou
    Pankaj Patel
    Ruta Sawant
    Jerry Clewell
    Namita Tundia
    [J]. Advances in Therapy, 2021, 38 : 2558 - 2570
  • [23] STATE PROCEDURE AND UNION RIGHTS: A COMPARISON OF THE EUROPEAN UNION AND THE UNITED STATES
    Clermont, Kevin M.
    [J]. AMERICAN JOURNAL OF COMPARATIVE LAW, 2009, 57 (01): : 258 - 266
  • [24] POTENTIAL OF US 7 SCORE IN EVALUATING OF DISEASE ACTIVITY OF PATIENTS WITH RHEUMATOID ARTHRITIS IN THE STATE OF REMISSION
    Hanova, P.
    Zavada, J.
    Hurnakova, J.
    Klein, M.
    Olejarova, M.
    Sleglova, O.
    Senolt, L.
    Komarc, M.
    Pavelka, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 664 - 664
  • [25] BARRIERS TO PRESCRIBING MEDICATIONS TO PATIENTS WITH MULTIPLE SCLEROSIS: A COMPARISON OF HEALTH CARE PROVIDER PERCEPTIONS IN EUROPEAN UNION (EU) AND THE UNITED STATES
    Narayanan, S.
    Khan, H.
    Gabriele, S.
    White, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A66 - A66
  • [26] Time in Remission Is Important for Improvement of Physical Function in Patients with Rheumatoid Arthritis (RA)
    Radner, Helga
    Alasti, Farideh
    Smolen, Josef S.
    Aletaha, Daniel
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1104 - S1105
  • [27] Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states
    Aletaha, D
    Ward, MM
    Machold, KP
    Nell, VPK
    Stamm, T
    Smolen, JS
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2625 - 2636
  • [28] Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
    Aletaha, D
    Ward, M
    Machold, K
    Nell, VPK
    Stamm, T
    Smolen, JS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 214 - 214
  • [30] Underuse of Methotrexate (MTX) in the Treatment of Rheumatoid Arthritis (RA) in the United States (US): Results of a Comprehensive Pharmaceutical Claims Analysis
    O'Dell, James R.
    Rohr, Melanie
    Cohen, Stanley B.
    Thorne, J. Carter
    Mikuls, Ted R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67